Table 1 Plasma fatty acids during the study
From: Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
μg FA/ml plasma | Start | End | WO 1 week | WO 4 weeks |
|---|---|---|---|---|
∑ FAs | 2999 ± 605 | 2811 ± 449* | 2767 ± 409* | 2677 ± 443** |
∑ SFAs | 956.4 ± 219.2 | 881.5 ± 151.1* | 875.4 ± 154.8 | 708.6 ± 207.1** |
C16:0 | 651.9 ± 172.0 | 589.5 ± 121.6** | 582.0 ± 119.6 | 558.2 ± 121.6** |
∑ MUFAs | 708.6 ± 207.1 | 573.8 ± 124.8*** | 613.4 ± 132.7* | 583.4 ± 140.5* |
C16:1n-7 | 39.8 ± 19.2 | 30.8 ± 11.6* | 34.6 ± 20.3 | 34.1 ± 17.6 |
C16:1n-9 | 6.91 ± 2.85 | 6.10 ± 2.08* | 6.63 ± 2.80 | 6.90 ± 2.75* |
C18:1n- 7 | 45.2 ± 15.4 | 36.5 ± 10.6** | 36.1 ± 6.6* | 36.4 ± 9.3 |
C18:1n- 9 | 568.2 ± 171.9 | 454.0 ± 101.0*** | 491.9 ± 112.1* | 463.4 ± 111.1* |
∑ n- 9 PUFAs | 3.10 ± 1.29 | 2.24 ± 0.48** | 2.75 ± 1.38 | 2.55 ± 1.01** |
C20:3n- 9 (MA) | 3.10 ± 1.29 | 2.24 ± 0.48** | 2.75 ± 1.38 | 2.55 ± 1.01** |
∑ n- 6 PUFAs | 1123 ± 190 | 1031 ± 180* | 1036 ± 148* | 1049 ± 141* |
C18:2n-6 | 862.7 ± 147.9 | 806.2 ± 153.3 | 814.5 ± 110.1 | 821.0 ± 93.7 |
C20:2n- 6 | 6.26 ± 2.43 | 4.91 ± 1.76*** | 5.52 ± 1.64 | 5.90 ± 2.08 |
C18:3n-6 | 7.75 ± 5.00 | 4.33 ± 2.41*** | 6.96 ± 4.075 | 7.16 ± 6.84 |
C20:3n- 6 | 40.5 ± 17.3 | 27.7 ± 9.93*** | 33.3 ± 9.78* | 35.4 ± 13.9 |
C20:4n- 6 (AA) | 197.8 ± 51.6 | 182.3 ± 41.1* | 170.3 ± 41.6*** | 173.0 ± 50.9* |
C22:4n- 6 | 4.33 ± 1.58 | 2.92 ± 0.71*** | 3.32 ± 0.92** | 3.70 ± 1.56** |
∑ n- 3 PUFAs | 200.8 ± 64.1 | 315.6 ± 62.8*** | 232.7 ± 62.9 | 197.0 ± 74.0 |
C18:3n-3 | 19.8 ± 8.17 | 16.6 ± 6.06* | 20.0 ± 8.85 | 19.0 ± 8.0 |
C20:5n- 3 (EPA) | 49.4 ± 27.1 | 109.7 ± 37.1*** | 61.7 ± 31.7 | 47.3 ± 32.7 |
C22:5n- 3 (DPA) | 17.6 ± 5.36 | 18.4 ± 4.27 | 18.0 ± 4.22 | 17.0 ± 5.43 |
C22:6n- 3 (DHA) | 108.1 ± 30.4 | 166.1 ± 30.5*** | 127.0 ± 29.5** | 108.4 ± 35.2 |
∑ n- 6:∑ n- 3 ratio | 6.10 ± 1.81 | 3.37 ± 0.82*** | 4.75 ± 1.42* | 5.88 ± 1.72 |